Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $7.49 USD
Change Today -0.44 / -5.55%
Volume 3.1M
PTX On Other Exchanges
As of 8:10 PM 04/21/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Cooper C. Collins

Former Chief Strategic Officer, Pernix Therapeutics Holdings, Inc.
AgeTotal Calculated CompensationThis person is connected to 10 board members in 2 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Cooper C. Collins served as the Chief Strategic Officer of Pernix Therapeutics Holdings, Inc. from May 2013 to April 15, 2014. Mr. Collins served as the President at Pernix Therapeutics Holdings, Inc. from January 2007 to May 2013 and served as its Chief Executive Officer from June 2008 to May 2013. Mr. Collins was responsible for acquiring products and assets, attracting investors and increasing the overall efficiency of the organization. He served as the President ...

Read Full Background

Corporate Headquarters*

10 North Park Place
Morristown, New Jersey 07960

United States

Phone: 800-793-2145
Fax: 862-260-8752

Board Members Memberships*

Former Chief Strategic Officer
Director and Chairman of Compensation Committee


Nicholls State University
Nicholls State University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PTX:US $7.49 USD -0.44


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PERNIX THERAPEUTICS HOLDINGS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at